Schedule a Call Back
Global life sciences leader Cytiva opens manufacturing facility in India
Articles- Oct 30,23
The manufacturing facility in Pune will double Cytiva’s manufacturing capacity in India and the Experience Center will provide critical training programs to accelerate the development of novel therapeutics.
As India works to become a biologics manufacturing hub, global life sciences leader Cytiva (now with the life sciences business from Pall Corporation) has opened a 33,000 sq ft manufacturing facility in Pune. The new facility will manufacture Cytiva’s bioprocessing equipment including tangential flow, virus filtration, and inactivation systems.
The facility will also be home to the Cytiva Experience Center which will provide immersive training programs for upstream and downstream technologies as well as digital and automation software. Additionally, customers will have greater access to thought leadership events and to demonstrations of Cytiva’s market-leading products, such as AKTA, Allegro, iCELLis and Sepax.
Rajan Sankaran, Commercial General Manager, India, Cytiva, said, “Fortifying our manufacturing footprint in India is critical to Cytiva’s operations in Asia-Pacific and long-term growth strategy. We must also play a key role in developing and nurturing the talent needed to meet the demand for biologic medicines. Our Cytiva Experience Center will provide the ongoing learning and development needed to accelerate the development of novel therapeutics and help India deliver on its Aatmanirbhar Bharat vision and mission.”
Located at Hinjawadi Rajiv Gandhi Infotech Park, this new facility complements Cytiva’s existing facilities in Bengaluru which include a Fast Trak Center, and a center for research and development across bioprocess, discovery, medical, and genomic medicine businesses.
According to Cytiva’s 2023 Global Biopharma Resilience Index, 65 per cent of biopharma executives in India say that the manufacturing of biologics in their country is likely to dramatically increase over the next three years. This is 15 per cent higher than the global average, and in line with India’s National Biopharma Mission to make India a hub for the development of novel and affordable vaccines and biologics to address the population’s health concerns.
Additionally, 46 per cent of biopharma executives in India say that they are focusing on onshoring drug manufacturing or increasing domestic sourcing over the next 12 months to boost supply chain resilience. However, 20 per cent of executives say that access to new equipment has become worse over the last two years, indicating a need to improve local access to equipment so that Indian companies can deliver affordable life-changing therapeutics domestically and to the region.
Cytiva aims to advance and accelerate the development of therapeutics. With nearly 16 000 associates in more than 40 countries, Cytiva’s broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma, and contract manufacturers.
Related Stories
Process Equipment
CuraTeQ biologics gains EMA GMP certification for biosimilars facility
The certification followed an inspection by EMA representatives , which evaluated key areas of the facility.
Read moreAutomation & Robotics
Honeywell introduces quality management review application for life sciences industry
With HQMR, users can also consolidate and summarise data from different sites in order to create a high-level overview that helps executives assess overall QMS performance across multiple facilities..
Read moreProcess Equipment
Nirma plans Rs 3,500 cr NCDs issue for GLSL acquisition and business growth
CRISIL, the rating agency, has assigned an “AA” rating to Nirma's proposed NCDs, reaffirming ratings on the company's existing bank facilities and debt instruments.
Read moreRelated Products
Programmable Controllers - Pcd-33a Series
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Pro-Med Instruments (P) Ltd offers a wide range of programmable controllers - PCD-33A Series.
Gasket Graphite Powder
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Arihant Packing & Gasket Company offers a wide range of gasket graphite powder.
Asahi Kasei expands 3D printing filament sales in North America
CHEMICAL PROCESS, FOOD/PHARMA EQUIPMENT & ANALYTICAL INSTRUMENTS
Asahi Kasei, a leading resin and compounding technology provider, has initiated the sales of 3D printing (3DP) filaments in North America through Asahi Kasei Plastics North America (APNA). The soft la Read more
latest News
Subscribe to iNoW
For Industry News on WhatsApp, Give a Miss Call on: +91 84228 74016
